| Name | POTE ankyrin domain family member B-like |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n LOC102723502, which encodes the novel secreted protein hHSS1, appears to function as a potent negative regulator of tumorigenesis. In glioblastoma model systems, experimental overexpression of hHSS1 (LOC102723502) results in significant alterations in cell cycle dynamics – notably, a reduction of cells in the G0/G1 phase and a concomitant increase in S and G2/M populations – as well as marked inhibition of cell migration, invasion, and tumor‐induced angiogenesis; these effects coincide with modulation of key signaling and metabolic pathways such as those related to BRCA1‐mediated DNA damage responses."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Although the abstracts provided cover a broad spectrum of topics – including the roles of cancer/testis antigens, apoptosis and genomic structural variations in malignancies and reproductive disorders – several studies highlight a recurring theme: novel or “testis‐selective” genes, including members of the POTE family, are frequently found to be aberrantly expressed in diverse cancers and are implicated in processes such as apoptotic regulation and adverse clinical outcomes (for instance, see."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "2", "end_ref": "6"}]}, {"type": "t", "text": " This pattern underscores the biological importance of evolutionarily novel, tissue‐restricted, and secreted factors – like hHSS1 – in controlling cell proliferation, migration and angiogenesis, as well as in modulating the tumor microenvironment."}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n In sum, the functional studies on LOC102723502/hHSS1 indicate that its secreted product acts as an anti‐tumorigenic agent by disrupting the cell cycle and inhibiting key processes involved in tumor progression. These findings, in the context of broader genomic and epigenetic research, support the therapeutic promise of targeting novel secreted factors for the treatment of highly malignant tumors.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Katiana S Junes-Gill, Chris E Lawrence, Christopher J Wheeler, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human Hematopoietic Signal peptide-containing Secreted 1 (hHSS1) modulates genes and pathways in glioma: implications for the regulation of tumorigenicity and angiogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1471-2407-14-920"}], "href": "https://doi.org/10.1186/1471-2407-14-920"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25481245"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25481245"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Tapan K Bera, Dawn A Walker, Richard J Sherins, et al. "}, {"type": "b", "children": [{"type": "t", "text": "POTE protein, a cancer-testis antigen, is highly expressed in spermatids in human testis and is associated with apoptotic cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2011.12.125"}], "href": "https://doi.org/10.1016/j.bbrc.2011.12.125"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22234308"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22234308"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Carter J Barger, Wa Zhang, Ashok Sharma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of the POTE gene family in human ovarian cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-018-35567-1"}], "href": "https://doi.org/10.1038/s41598-018-35567-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30459449"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30459449"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Qi Wang, Xuefei Li, Shengxiang Ren, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Serum levels of the cancer-testis antigen POTEE and its clinical significance in non-small-cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0122792"}], "href": "https://doi.org/10.1371/journal.pone.0122792"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25860145"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25860145"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "N Guediche, L Tosca, A Kara Terki, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Array comparative genomic hybridization analysis of small supernumerary marker chromosomes in human infertility."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Reprod Biomed Online (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.rbmo.2011.08.014"}], "href": "https://doi.org/10.1016/j.rbmo.2011.08.014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22116069"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22116069"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Pavel Dobrynin, Ekaterina Matyunina, S V Malov, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The novelty of human cancer/testis antigen encoding genes in evolution."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Genomics (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2013/105108"}], "href": "https://doi.org/10.1155/2013/105108"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23691492"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23691492"}]}]}]}
|
| NCBI Gene ID | 102723502 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
LOC102723502 has 18 functional associations with biological entities spanning 4 categories (functional term, phrase or reference, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA) extracted from 4 datasets.
Click the + buttons to view associations for LOC102723502 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with LOC102723502 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with LOC102723502 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of LOC102723502 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with LOC102723502 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |